Gries Financial LLC Grows Position in The Procter & Gamble Company (NYSE:PG)

Gries Financial LLC boosted its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 728.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,900 shares of the company’s stock after purchasing an additional 21,896 shares during the period. Procter & Gamble makes up approximately 0.8% of Gries Financial LLC’s portfolio, making the stock its 22nd biggest holding. Gries Financial LLC’s holdings in Procter & Gamble were worth $4,313,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in the stock. Itau Unibanco Holding S.A. acquired a new position in Procter & Gamble during the second quarter valued at approximately $28,000. Fairway Wealth LLC purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at $29,000. Ruedi Wealth Management Inc. lifted its holdings in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares in the last quarter. POM Investment Strategies LLC purchased a new stake in Procter & Gamble during the 2nd quarter worth $34,000. Finally, Quest Partners LLC acquired a new stake in Procter & Gamble in the 2nd quarter valued at $36,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $1,202,751.55. Following the sale, the chief executive officer now directly owns 269,172 shares in the company, valued at $46,203,373.80. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the transaction, the insider now directly owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jon R. Moeller sold 7,007 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the completion of the sale, the chief executive officer now directly owns 269,172 shares of the company’s stock, valued at $46,203,373.80. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 383,194 shares of company stock worth $65,140,718. 0.18% of the stock is owned by insiders.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock traded up $0.01 during trading hours on Friday, reaching $171.28. The company’s stock had a trading volume of 8,372,536 shares, compared to its average volume of 6,692,838. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The company’s 50 day simple moving average is $171.77 and its 200 day simple moving average is $167.11. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The stock has a market cap of $404.24 billion, a P/E ratio of 28.45, a price-to-earnings-growth ratio of 3.74 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. Procter & Gamble’s revenue was down .6% on a year-over-year basis. During the same quarter last year, the company posted $1.83 earnings per share. As a group, analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.35%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 66.94%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on PG. Stifel Nicolaus upped their target price on Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research report on Monday, July 22nd. Royal Bank of Canada lifted their price target on shares of Procter & Gamble from $157.00 to $164.00 and gave the stock a “sector perform” rating in a research note on Wednesday, July 31st. DA Davidson reissued a “neutral” rating and issued a $159.00 price objective on shares of Procter & Gamble in a research report on Tuesday. Dbs Bank lowered Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target for the company in a report on Thursday, August 29th. Nine investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and an average price target of $176.21.

Get Our Latest Analysis on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.